Careers  |  Sign In  |  Register  |   Twitter

Latest in Oncology

With many people avoiding their imminent colonoscopy, Cologuard, may be the non-invasive saving grace. According to CBS News, the new at-home test for colon cancer not only checks a stool sample sent by the patient for blood that may suggest a tumor, but also looks for DNA that could be related to cancer...
NewLink Genetics and Roche have teamed up to develop NewLink’s cancer immunothereapy in a $1 billion deal, Reuters reports. The NewLink inhibitor, NLG919, works to disrupt the process through which tumors elude a patient’s immune system. NLG919 is currently in early-stage testing for use in...
An experimental T-Cell therapy which genetically programs a patient’s cells to fight disease is showing promise in bringing remission to leukemia patients, The New York Times reports. According to a study published in The New England Journal of Medicine 19 of 30 patients with acute lymphoblastic...